论文部分内容阅读
Blood DCs manufactured with the automated CliniMACS Prodigy(R)CD1c/CD304 enrichment and activation s
【作 者】
:
【机 构】
:
Miltenyi Biotec GmbH,Bergisch Gladbach,Germany Ra
【出 处】
:
2016年国际树突状细胞研讨会(The 14th International Symposium on Dendriti
【发表日期】
:
2016年5期
其他文献
会议
会议
Dissecting human skin DC CLR mediated uptake and cross-presentation of tumor specific glyco-conjugat
会议
Protein aggregation captures the stable cellular proteome permissive for MHC class I cross presentat
会议
Dendritic cell(DC)–based immunotherapy has been expected to shed lights on the field of cancer treatments.However,even in the murine model,DC-based immunotherapy has not been as much effective as expe
会议